Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer
NCT00003760
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
irofulven
Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
[object Object]
[object Object]
[object Object]